Cargo Therapeutics Inc (Ticker: CRGX US) is in a Stanford-born biotech startup, focusing on developing cell therapies for cancer. The company is scheduled to list on NASDAQ GS on November 10, 2023. Cargo Therapeutics Inc is offering 18.75 million shares within an expected price range of USD 15.00 to 17.00. The total offer size is USD 318.75 million. JP Morgan Securities, Cowen & Co, Jefferies LLC, and Truist Securities Inc manage the offering. The company plans to allocate a significant portion of the IPO proceeds to fund Phase II trials of its lead Car T-Cell therapy candidate, CRG-022, and further research and development, providing cash flow into 2025.